---
$id: https://graph.org.ai/products/commodity/51283611
$type: Product
source: UNSPSC
code: "51283611"
title: "Rifamycin sodium"
class: "51283600"
classTitle: "Rifamycin antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rifamycin sodium

**UNSPSC Code**: 51283611
**Class**: [Rifamycin antibacterials](Rifamycin antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitubercular agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 32086GS35Z. European Medicines Agency schedules Rifamycin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04246MIG. Rifamycin sodium generally arises in the molecular formula C37H46NO12.NA. The term 'rifamycin sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule rifamycin sodium under HS 29419000 and SITC 54139. As of Q4 2014, RIFAMYCIN SODIUM remains US FDA's Preferred Term for this commodity. Rifamycin sodium bears US NLM identifiers UMLS ID C0771754 and NCI Concept Code C95605. SMILES: CC1C(C2C3C(CC(C2O)NC(=O)/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H](/C=C/O[C@@]4(C(=O)C3C1O4)C)OC)C)OC(=O)C)C)O)C)O)C)/C)[O-])O.[NA+].

